885 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

ESSA Competitors or Alternatives

ESSA's top competitors include Clovis Oncology, AstraZeneca and Sanofi.

Unlock 14 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

ESSA's company profile

David R. Parkinson

President & CEO

86/100
35
$227.6M
$8.8M
  • $227.6M
    $8.8M
  • 35
    $227.6M
  • $8.8M
  • 86/100
  • 35
  • $227.6M
  • $8.8M
View ProfileView
1
ESSA's Competitor - Clovis Oncology logo

CEO

- -
250 - 500
$763.3M
$100M - 500M
  • $763.3M
    $100M - 500M
  • 250 - 500
    $763.3M
  • $100M - 500M
  • - -
  • 250 - 500
  • $763.3M
  • $100M - 500M
View ProfileView
2
ESSA's Competitor - AstraZeneca logo

Pascal Soriot

CEO

75/100
94,300
$100M
$55B
  • $100M
    $55B
  • 94,300
    $100M
  • $55B
  • 75/100
  • 94,300
  • $100M
  • $55B
View ProfileView
3
ESSA's Competitor - Sanofi logo

Paul Hudson

CEO

64/100
82,878
- -
$42.8B
  • - -
    $42.8B
  • 82,878
    - -
  • $42.8B
  • 64/100
  • 82,878
  • - -
  • $42.8B
View ProfileView
4
ESSA's Competitor - Inovio logo

Jacqueline Shea

President & CEO

47/100
320
$296.4M
$ < 1M
  • $296.4M
    $ < 1M
  • 320
    $296.4M
  • $ < 1M
  • 47/100
  • 320
  • $296.4M
  • $ < 1M
View ProfileView
5
ESSA's Competitor - Agios logo

Brian Goff

CEO

85/100
390
$226M
$37M
  • $226M
    $37M
  • 390
    $226M
  • $37M
  • 85/100
  • 390
  • $226M
  • $37M
View ProfileView
ESSA's top 17 competitors are Clovis Oncology, AstraZeneca, Sanofi, Agenus, Inovio, Agios, Exelixis, Geron, Array BioPharma, TESARO, Allergan, Diffusion Pharmaceuticals, Nektar, Kesios Therapeutics, Genentech, Kite Pharma and VBI. Together they have raised over 8.3B between their estimated 213.7K employees. ESSA has 35 employees and is ranked 15th among it's top 10 competitors. The top 10 competitors average 11,876.

ESSA VS Clovis Oncology

Clovis Oncology has been one of ESSA's top competitors. Clovis Oncology was founded in 2009, and is headquartered in Boulder, Colorado. Clovis Oncology competes in the Pharmaceuticals industry. Clovis Oncology generates $124.2M more revenue vs. ESSA.

ESSA VS AstraZeneca

AstraZeneca is a top competitor of ESSA. AstraZeneca is a Public company that was founded in Cambridge, England in 1999. Like ESSA, AstraZeneca also competes in the Pharmaceuticals industry. AstraZeneca has 94,265 more employees vs. ESSA.

ESSA VS Sanofi

Sanofi is perceived as one of ESSA's biggest rivals. Sanofi was founded in 1994, and its headquarters is in Paris, Île-de-France. Like ESSA, Sanofi also operates in the Pharmaceuticals field. Sanofi has 82,843 more employees than ESSA.

Looking for similar companies to ESSA?

Similar Companies

Pharmaceuticals companies in Vancouver

See 81 companies 
Pharmaceuticals & Biotechnology companies in Vancouver

See 204 companies 
Pharmaceuticals companies in British Columbia

See 149 companies 
Pharmaceuticals & Biotechnology companies in British Columbia

See 364 companies 
Pharmaceuticals companies in Canada

See 1,054 companies 
Pharmaceuticals & Biotechnology companies in Canada

See 2,090 companies 
Pharmaceuticals companies with revenue in $5.0-25M range

See 2,477 companies 
Pharmaceuticals companies with employees in 25-100 range

See 2,866 companies 
Pharmaceuticals & Biotechnology companies with revenue in $5.0-25M range

See 5,543 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for ESSA and ESSA's Competitors

Today 12:41 AMReuters
France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in rare immunology diseases, ...
June 2, 2025PharmaTimes
Updated guidance from NICE expands eligibility for dapagliflozin us...
June 2, 2025Law 360
A Delaware federal judge has dismissed a pair of Allergan units from a suit alleging two biotechnology companies infringed patents related to Botox pro...
Today 2:02 AMFinanzNachrichten
SOUTH SAN FRANCISCO (dpa-AFX) - Genentech, a member of the Roche Group (RHHBY), announced positive results from the Phase III IMforte study of Tecentri...
June 2, 2025Investing.com
Sanofi extends license option with Nurix's STAT6 program...
June 2, 2025Applied Clinical Trials
In the DESTINY-Breast09 study, Enhertu (fam-trastuzumab deruxtecan-nxki) plus pertuzumab reduced the risk of disease progression or death by 44% in pat...
June 2, 2025Openpr
The Global Aesthetic Service Market is estimated to be valued at USD 21.94 Bn in 2025 and is expected to reach USD 36.40 Bn by 2032, exhibiting a compo...
Today 1:46 AMNasdaq
(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced positive results from the Phase III IMforte study of Tecentriq (atezolizumab) in ...
June 2, 2025STAT News
Kymera Therapeutics reported that an experimental drug designed to rival Sanofi and Regeneron's blockbuster therapy Dupixent succeeded in a closely wat...
June 1, 2025STAT News
AstraZeneca CEO Pascal Soriot views the company's stock price - up just 10% year-to-date - as a marker of how he is doing. He'd like it to be higher....

Frequently Asked Questions about ESSA

  1. Who are ESSA's top competitors?

    ESSA's top 3 competitors are Clovis Oncology, AstraZeneca, Sanofi.

  2. Who is similar to ESSA?

    Clovis Oncology is the most similar to ESSA. AstraZeneca and Sanofi are also similar to ESSA.

  1. Are ESSA and Clovis Oncology competitors?

    Yes, Clovis Oncology is one of ESSA’s top competitors.